TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Total Liabilities (Quarterly) : 102.43M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 102.43M |
| March 31, 2026 | 105.07M |
| December 31, 2025 | 105.67M |
| September 30, 2025 | 118.20M |
| June 30, 2025 | 121.85M |
| March 31, 2025 | 122.51M |
| December 31, 2024 | 130.15M |
| September 30, 2024 | 118.94M |
| June 30, 2024 | 119.65M |
| March 31, 2024 | 117.86M |
| December 31, 2023 | 121.28M |
| Date | Value |
|---|---|
| September 30, 2023 | 122.42M |
| June 30, 2023 | 126.32M |
| March 31, 2023 | 95.56M |
| December 31, 2022 | 99.66M |
| September 30, 2022 | 48.80M |
| June 30, 2022 | 20.76M |
| March 31, 2022 | 22.51M |
| December 31, 2021 | 27.33M |
| September 30, 2021 | 30.82M |
| June 30, 2021 | 30.63M |
| March 31, 2021 | 31.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 171.45M |
| Shareholders Equity (Quarterly) | 69.02M |
| Debt to Equity Ratio | 1.317 |
| Current Ratio | 3.372 |
| Net Debt Paydown Yield | 1.85% |